Search

everythinglearnresearchcommunity

for

Search:↓

Neuroendocrine paraneoplastic syndromes often show skin changes, helping early diagnosis and requiring a team approach for best care.

The herbal mixture RAA promotes hair growth and could be an alternative treatment for hair loss.

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Melatonin could be an effective treatment for Alzheimer's Disease and rosacea.

Morroniside may help hair grow and stay in its growth phase by affecting certain cell signals.

Antiandrogen treatments can help with various women's health issues but often require ongoing use.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Some herbs show promise as antiandrogenic agents.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Blocking a specific receptor slows down hair loss in mice.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Topical nitroglycerin spray effectively prevents scalp necrosis in hair transplant patients.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.